Which of the following is not true about dopamine action
## Core Concept
Dopamine is a catecholamine neurotransmitter that plays a crucial role in various physiological and psychological processes. It acts on dopamine receptors, which are G protein-coupled receptors, to exert its effects. Dopamine is involved in reward, motivation, movement, and regulation of blood pressure.
## Why the Correct Answer is Right
Dopamine's effects are primarily mediated through its action on five subtypes of dopamine receptors: D1, D2, D3, D4, and D5. These receptors are coupled to Gs or Gi/o proteins, leading to either an increase or decrease in cyclic AMP (cAMP) levels within the cell, depending on the receptor subtype. Dopamine's action on D1-like receptors (D1 and D5) generally increases cAMP, while its action on D2-like receptors (D2, D3, and D4) decreases cAMP.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, statements about dopamine increasing renal blood flow and sodium excretion are true due to its action on dopamine receptors in the kidneys.
- **Option B:** Similarly, this option is not provided, but statements about dopamine stimulating D2 receptors to decrease prolactin release are true. Dopamine acts on D2 receptors in the pituitary gland to inhibit prolactin secretion.
- **Option C:** Without the specific statement, it's hard to address directly, but generally, dopamine's role in the brain's reward pathways and its involvement in psychosis and schizophrenia are well-established.
- **Option D:** This option is marked as the correct answer but without the statement, we can infer that it likely suggests something not true about dopamine action, such as dopamine not crossing the blood-brain barrier (which is true but let's assume there's a more specific claim).
## Clinical Pearl / High-Yield Fact
A key point to remember is that **dopamine** has a unique characteristic: at low doses, it primarily stimulates **D1 receptors** in the renal and mesenteric blood vessels, causing vasodilation. At moderate doses, it stimulates **Ξ²1-adrenergic receptors** in the heart, increasing heart rate and contractility. At high doses, it stimulates **Ξ±1-adrenergic receptors**, causing vasoconstriction.
## Correct Answer: D.